Glufast On Insulin Glargine Trial in Type 2 DM

PHASE4CompletedINTERVENTIONAL

Enrollment

167

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

July 31, 2009

Study Completion Date

September 30, 2009

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Mitiglinide

mitiglinide 10mg three times a day before a meal

DRUG

Voglibose

voglibose 0.2mg three times a day before a meal

Trial Locations (1)

The Catholic Univ. of Korea, Kangnam ST. Mary's Hospital, Seoul